Trials / Sponsors / Tianjin Hemay Pharmaceutical Co., Ltd

Tianjin Hemay Pharmaceutical Co., Ltd

Industry · 13 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Completed	Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis Active Ankylosing Spondylitis	Phase 2	2022-08-05
Completed	A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis Psoriasis	Phase 3	2022-01-20
Recruiting	A Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer Breast Cancer	Phase 3	2022-01-08
Completed	Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects Psoriasis	Phase 1	2021-04-29
Completed	A Phase 2 Study of Hemay007 in Patients With Rheumatoid Arthritis Rheumatoid Arthritis	Phase 2	2021-03-26
Terminated	A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease Behçet Disease	Phase 2	2020-11-30
Completed	A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients Atopic Dermatitis	Phase 2	2020-04-24
Terminated	Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis Ulcerative Colitis	Phase 2	2019-08-13
Completed	Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis Psoriasis	Phase 2	2019-05-30
Completed	A Phase I Clinical Study of Hemay808 Safety Issues	Phase 1	2019-04-08
Completed	Study Evaluating Hemay022 in Combination With Endocrine Therapy In Subjects With ER Positive and HER2 Positive Breast Cancer	Phase 1	2017-10-16
Completed	Study Evaluating Hemay022 In Subjects With HER2-Positive Advanced Breast Cancer HER2 Positive Breast Cancer	Phase 1	2015-10-14
Terminated	Study Evaluating Hemay020 In Subjects With Advanced Solid Cancer Neoplasms，Non-Small Cell Lung Cancer	Phase 1	2015-07-03